Share：
Share this content in WeChat
X
[Chinese][PDF]111065
• Review •
Research progress of differentiating stages of thyroid-associated ophthalmopathy with MRI
HUO Lei  XIA Shuang 

DOI:10.3969/j.issn.1674-8034.2015.01.013.


[Abstract] Thyroid associated ophthalmopathy is one of the most commonly occurring diseases, which is divided into two stages in clinic: active stage and stable stage, and to differentiate the stages correctly and objectively influences the therapeutic schedule and prognosis. MRI is more and more important in differentiating the stage of TAO because of its excellent soft-tissue resolution and multiple plane imaging. Especially, dynamic enhanced MRI can differentiate the stage of TAO intuitively and quantitatively.
[Keywords] Graves’ disease；Magnetic resonance imaging；Extraocular muscle

HUO Lei Da Gang Community Hospital, Tianjin Binhai New Area, Tianjin 300270, China

XIA Shuang* The First Central Hospital, Tianjin Medical University, Tianjin 300192, China

*Correspondence to: XIA S, E-mail: xiashuang77@163.com

Conflicts of interest   None.

Received  2014-08-23
Accepted  2014-10-26
DOI: 10.3969/j.issn.1674-8034.2015.01.013
DOI:10.3969/j.issn.1674-8034.2015.01.013.

[1]
Garrity JA, Bahn RS. Pmhogenesis of Graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol, 2006, 142(1): 147-153.
[2]
Heufelder AE. Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord, 2000, 1(1-2): 87-95.
[3]
Douglas RS, Afifiyan NF, Hwmag CJ, et a1. Increased generation of fibrocytes in thyroid-associated ophthalmopathy. Clin Endocrinol Metab, 2010, 95(1): 430-438.
[4]
Mourits MP, Koornneef L, Wiersinga WM, et a1. Clinical criteria for assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br Jophthalmo, 1989, 73(8): 639-644.
[5]
Kahaly GJ. Recent developments in Graves’ ophthalmopathy imaging. Endocrinol Invest, 2004, 27(3): 254-258.
[6]
Nugent RA, Belkin RI, Neigel JM, et al. Graves orbitopathy:correlation of CT and clinical findings. Radiology, 1990, 177(3): 675-682.
[7]
范艳飞，沈洁，李际敏，等. MRI定量指标用于评定甲状腺相关眼病活动分期的可行性探讨：附84例报告．新医学, 20l0, 41 (3): 160-163.
[8]
Hosten N, Sander B, Cordes M, et al. Graves’ ophthalmopathy: MR imaging of the orbits. Radiology, 1989, 172(3): 759-762.
[9]
Just M, Kahaly G, Higer HP, et al. Graves ophthalmopathy: role of MR imaging in radiation therapy. Radiology, 1991, 179(1): 187-190.
[10]
Bailey CC, Kabala J, Laitt R, et al. Magnetic resonance imaging in thyroid eye disease. Eye (Lond), 1996, 10(5): 617-619.
[11]
姜虹，王振常．眼外肌功能MRI研究进展．国际医学放射学杂志, 2011, 34(1): 41-44.
[12]
Mayer EJ, Fox DL, Herdman G, et al. Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. Eur J Radiol, 2005, 56(1): 20-24.
[13]
Kirsch EC, Kaim AH, Oliveria MG, et a1. Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy: a pilot study at 1.5 T. Neuroradiology, 2010, 52(2): 9l-97.
[14]
Kirseh E, Hammer B, von Arx G．Graves’ orbitopathy: current imaging procedures. Swiss Med Wkly, 2009, 139(43-44): 618-623.
[15]
Ostandorp M, Post MJ, Backes WH. Vessel growth and functin: depiction with contrast-enhanced MR imaging. Radiology, 2009, 251(2): 317-333.
[16]
O' Connor JP, Jackson A, Parker GJ. et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer, 2007, 96(2): 189-195.
[17]
Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Mag Reson Imaging,1999, 10(3): 223-232.
[18]
Taoka T, Iwasaki s, Uchida H, et al. Enhancement pattern of normal extraocular muscles in dynamic contrast-enhanced MR imaging with fat suppression. Acta Radial, 2000, 41(3): 211-216.
[19]
Toshiaki T, Masahiko S, Hiroyuki N, et, al. Evaluation of extraocular muscles using dynamic contrast enhanced MRI in patients with chronic thyroid orbitopathy. Comput Assist Tomogr, 2005, 29(1): 115-120.
[20]
姜虹，王振常、鲜军舫，等. Graves眼病眼外肌受累特点的MR动态增强研究．磁共振成像, 2012, 3(5): 341-346.
[21]
Jiang H, Wang ZC, Xian JF, et al. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves’ ophthalmopathy for assessment of disease activity. Acta Radiol, 2012, 53(1): 87-94.
[22]
Tachibana S, Murakami T, Noguchi H, et a1. Orbital magnetic resouance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy. Eudocr J, 2010, 57(10): 853-861.

PREV The research progress of multimodality functional MRI in type 2 diabetic encephalopathy
NEXT Research in magnetic resonance imaging of triple-negative breast cancer
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn